glp 1 and type 2 diabetes GLP-1 receptor agonism: a transformative approach for managing type-2 obesity | Saudi Pharmaceutical Journal The effects of glucagon-like peptide-1

Additionally, patients with known allergy to semaglutide or any product component should not use this medication

Real-world data from the STEP, SURMOUNT, SUSTAIN, and SURPASS trials shows clear patterns: weight loss is fastest in the first 20 weeks, slows after 40 weeks, and approaches a plateau by 60 to 68 weeks for semaglutide and 72 weeks for tirzepatide

Enhanced neurogenesis by berberine leads to improved cognitive recovery following TBI

doi: 10.3390/pharmaceutics15010118

10 People Share Their Stories, accessed April 22, 2025, Mounjaro, Ozempic, Wegovy, Zepbound: How Do They Differ

Autism is a complex neurodevelopmental disorder with increasing diagnoses (Hyman et al